MAPT and amyotrophic lateral sclerosis: A recent study published in Nature Medicine identified the potential of tau and TDP-43 proteins in plasma EVs as a diagnostic biomarker for frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS)[3].